tiprankstipranks
Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
US Market

Oncternal Therapeutics (ONCT) Income Statement

451 Followers

Oncternal Therapeutics Income Statement

Last quarter (Q1 2024), Oncternal Therapeutics's total revenue was $569.00K, an increase of 180.30% from the same quarter last year. In Q1, Oncternal Therapeutics's net income was $-8.39M. See Oncternal Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.44M$ 785.00K$ 1.49M$ 4.32M$ 0.00$ 2.42M
Cost of Revenue
------
Gross Profit
$ 1.15M$ 785.00K$ 1.49M$ 4.32M--
Operating Expense
$ 39.50M$ 42.50M$ 46.44M$ 35.68M$ 17.54M$ 17.45M
Operating Income
$ -38.35M$ -41.71M$ -44.95M$ -31.37M$ -17.54M$ -15.02M
Net Non Operating Interest Income Expense
$ 1.97M$ 2.23M$ 777.00K$ 33.00K$ 16.00K$ 188.00K
Other Income Expense
$ 11.00K-$ -9.00K-$ 301.00K$ -19.36M
Pretax Income
$ -36.38M$ -39.48M$ -44.17M$ -31.33M$ -17.23M$ -34.19M
Tax Provision
$ -58.00K$ -58.00K$ -2.82M---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -36.38M$ -39.48M$ -44.17M$ -31.33M$ -17.23M$ -34.19M
Basic EPS
$ -6.26$ -13.43$ -0.84$ -0.64$ -0.85$ -3.31
Diluted EPS
$ -6.26$ -13.43$ -0.84$ -0.64$ -0.85$ -3.31
Basic Average Shares
$ 123.59M$ 2.94M$ 52.59M$ 49.32M$ 20.30M$ 10.33M
Diluted Average Shares
$ 123.59M$ 2.94M$ 52.59M$ 49.32M$ 20.30M$ 10.33M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.64M$ 42.50M$ 46.44M$ 35.68M$ 17.54M$ 17.45M
Net Income From Continuing And Discontinued Operation
$ -36.38M$ -39.48M$ -44.17M$ -31.33M$ -17.23M$ -34.19M
Normalized Income
$ -7.08M-$ -46.99M-$ -17.23M$ -14.83M
Interest Expense
-----$ 0.00
EBIT
$ -28.14M$ -39.48M$ -44.17M$ -31.33M$ -17.54M$ -15.02M
EBITDA
$ -28.60M$ -41.11M$ -44.24M$ -31.33M$ -17.54M$ -15.02M
Currency in USD

Oncternal Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis